drugset / Trial / NCT01890941

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

NCT01890941 ↗

Summary

The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.

Timeline

Start
—
Primary completion
2014-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ozagrel Small molecule — Other

Indications